Capstone Clinical Trials, Inc.
Warning letter issued February 28, 2007 · Homewood, Alabama
- Inspection
- Sep 11 – Sep 14, 2006
- Investigators
- Barbara Wright· Dana M. Daigle
- Pages
- 6
In short: On February 28, 2007, FDA sent a warning letter to Capstone Clinical Trials, Inc. in Homewood, Alabama.
Inside this warning letter
The full warning letter
Every page of the warning letter, exactly as written.
Get the full warning letterThis inspection in context
Barbara Wright
6 documents · 2000–2025
Cites 312.60 (general responsibilities of investigators) more than any other section. Most of their documents are for sites in Alabama.
The firmCapstone Clinical Trials, Inc. history
The site's inspection history, in date order.
Similar documentsMore warning letters
Browse other documents of this type.
Questions about this warning letter
Who inspected Capstone Clinical Trials, Inc.?
Barbara Wright and Dana M. Daigle are named on this Warning letter, for the inspection of Sep 11 – Sep 14, 2006. Each investigator has a profile showing what they cite most.
When was Capstone Clinical Trials, Inc. inspected by FDA?
The inspection ran Sep 11 – Sep 14, 2006, and the Warning letter is dated February 28, 2007.
How do I get the full Warning letter for Capstone Clinical Trials, Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.